Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luojia Yang

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
European Urology|April 20, 2020
Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional AnalysisTaoping Shi, Qingbo Huang, Kan Liu, et al.
Nature Communications|November 14, 2022
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Communications|December 10, 2024
Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Biomedical Engineering|March 21, 2025
Cas12a-knock-in mice for multiplexed genome editing, disease modelling and immune-cell engineeringKaiyuan Tang, Liqun Zhou, Xiaolong Tian, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
European Urology|April 20, 2020
Robot-assisted Cavectomy Versus Thrombectomy for Level II Inferior Vena Cava Thrombus: Decision-making Scheme and Multi-institutional AnalysisTaoping Shi, Qingbo Huang, Kan Liu, et al.
Nature Communications|November 14, 2022
Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Communications|December 10, 2024
Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylationChengyu Shi, Ying Wang, Minjie Wu, et al.
Nature Biomedical Engineering|March 21, 2025
Cas12a-knock-in mice for multiplexed genome editing, disease modelling and immune-cell engineeringKaiyuan Tang, Liqun Zhou, Xiaolong Tian, et al.
Pageof 4